Cormark upgraded shares of STERIS’ (TSE:STE – Free Report) to a moderate buy rating in a research note issued to investors on Monday morning,Zacks.com reports.
Separately, Atb Cap Markets upgraded shares of STERIS’ to a “strong-buy” rating in a research note on Sunday, December 22nd.
STERIS’ Price Performance
About STERIS’
STERIS’s MISSION IS TO HELP OUR CUSTOMERS CREATE A HEALTHIER AND SAFER WORLD by providing innovative healthcare and life science product and service solutions around the globe by providing innovative healthcare and life science product and service solutions around the globe.
Recommended Stories
- Five stocks we like better than STERIS’
- Why Are These Companies Considered Blue Chips?
- 100% Upside? Amprius Technologies Is Charged for Growth in 2025
- What is MarketRank™? How to Use it
- The 5 Stocks Congress Bought Most in 2024: Top Picks for 2025
- Most active stocks: Dollar volume vs share volume
- 3 Stocks Set to Benefit From Trump’s “Drill, Baby, Drill” Policy
Receive News & Ratings for STERIS’ Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS’ and related companies with MarketBeat.com's FREE daily email newsletter.
